When compared with qPCR-based MRD, RNA-seq-based MRD showed comparable performance in terms of sensitivity, specificity, positive/negative predictive value using 3-log reduction as a cut-off in RUNX1-RUNX1T1 AML (Table S11). This evidence concerns the gene RUNX1 and acute myeloid leukemia.